Synbiobeta

Synbiobeta Contact information, map and directions, contact form, opening hours, services, ratings, photos, videos and announcements from Synbiobeta, Biotechnology company, Pleasant Hill, CA.

Synthetic Biology Events & Industry Information
🌍 Global Synthetic Biology Conference
📅 May 4-7, 2026 in San Jose
Join us!

tinyurl.com/2uc677rn Built With Biology is the premier innovation network for biological engineers, innovators, entrepreneurs, and investors who share a passion for using biology to build a better, more sustainable planet. We provide our community members with

personal and professional development support, as well as valuable opportunities for networking, partnership, collaboration, and education. Every year we host The Global Synthetic Biology Summit which showcases the cutting-edge developments in biology that are transforming how we fuel, heal, and feed the world. In addition, we stage a variety of other conferences, thought leader retreats, and local meet-ups throughout the year, in both the United States and around the world.

10x Genomics has entered a multi-year collaboration with Cleveland Clinic to leverage its single cell and spatial techno...
06/18/2026

10x Genomics has entered a multi-year collaboration with Cleveland Clinic to leverage its single cell and spatial technology platforms for identifying biomarkers that predict responses to antibody-drug conjugates in bladder cancer patients. This partnership aims to generate a comprehensive dataset linking tumor biology with clinical outcomes, ultimately advancing diagnostic applications in oncology.

https://www.prnewswire.com/news-releases/10x-genomics-and-cleveland-clinic-collaborate-to-advance-research-in-diagnostic-applications-of-single-cell-and-spatial-technologies-in-patients-with-bladder-cancer-302802437.html

Want to stay ahead in biotech? Subscribe to our newsletter for more 🧬https://www.syntheticbiologysummit.com/2027/early-bird?utm_source=Newsletter&utm_medium=Newsletter&utm_campaign=Digest_649&utm_content=Button%203

Anthropic's latest AI release, Claude Fable 5, has drawn criticism from users and developers for its stringent safety me...
06/18/2026

Anthropic's latest AI release, Claude Fable 5, has drawn criticism from users and developers for its stringent safety measures, which block or downgrade requests related to sensitive topics such as biology and cybersecurity. The backlash highlights the need for transparency in AI functionalities, as many users experienced unexpected model behaviors without clear notifications, prompting Anthropic to acknowledge the shortcomings and commit to clearer communication in future updates.

https://www.wsj.com/tech/ai/anthropic-fable-restrictions-ai-developers-cd9bf57c

Want to stay ahead in biotech? Subscribe to our newsletter for more 🧬https://www.syntheticbiologysummit.com/2027/early-bird?utm_source=Newsletter&utm_medium=Newsletter&utm_campaign=Digest_649&utm_content=Button%203

Boltz has launched BoltzMol-1, a small molecule hit-discovery pipeline, and BoltzProt-1, an advanced protein design tool...
06/18/2026

Boltz has launched BoltzMol-1, a small molecule hit-discovery pipeline, and BoltzProt-1, an advanced protein design tool, both validated through extensive AI-driven experiments. The new Boltz API facilitates seamless integration into existing workflows, offering predictions at just $0.025, and partners with leading biotech platforms including Benchling and Amazon Bio Discovery to enhance accessibility for researchers.

https://boltz.bio/boltzmol-boltzprot-api

Want to stay ahead in biotech? Subscribe to our newsletter for more 🧬https://www.syntheticbiologysummit.com/2027/early-bird?utm_source=Newsletter&utm_medium=Newsletter&utm_campaign=Digest_649&utm_content=Button%203

AI research lab Radical Numerics launches with $50 million in seed funding led by Emergence Capital, aiming to build gen...
06/18/2026

AI research lab Radical Numerics launches with $50 million in seed funding led by Emergence Capital, aiming to build general biological intelligence for human health and biodefense. The funding will help scale their multimodal models, including Omnii, a next-gen genomic language model, while addressing biosecurity concerns related to AI's potential misuse in designing harmful biology.

https://www.businesswire.com/news/home/20260615558179/en/AI-Lab-Radical-Numerics-Launches-with-%2450M-Seed-Round-To-Build-General-Biological-Intelligence

Want to stay ahead in biotech? Subscribe to our newsletter for more 🧬https://www.syntheticbiologysummit.com/2027/early-bird?utm_source=Newsletter&utm_medium=Newsletter&utm_campaign=Digest_649&utm_content=Button%203

The EVERY Company partners with Huvepharma to expand its manufacturing capabilities, increasing production of its flagsh...
06/18/2026

The EVERY Company partners with Huvepharma to expand its manufacturing capabilities, increasing production of its flagship OvoPro™ egg protein product fourfold. This strategic move addresses a significant rise in orders, with B2B and retail demand soaring due to national placements in major retailers like Target and Walmart, and the need for stable, high-quality protein ingredients in the food industry.

https://www.businesswire.com/news/home/20260615549357/en/EVERY-and-Huvepharma-Announce-4x-Production-Capacity-Expansion

Want to stay ahead in biotech? Subscribe to our newsletter for more 🧬
https://www.syntheticbiologysummit.com/2027/early-bird?utm_source=Newsletter&utm_medium=Newsletter&utm_campaign=Digest_649&utm_content=Button%203

Switch Bioworks has initiated field trials of its genetically engineered microbial fertilizer, approved by the USDA and ...
06/18/2026

Switch Bioworks has initiated field trials of its genetically engineered microbial fertilizer, approved by the USDA and EPA, aimed at enhancing nitrogen delivery to corn crops. This trial addresses rising fertilizer costs and supply chain vulnerabilities by utilizing living microbes to extract nitrogen from the air, potentially transforming agricultural practices in the Midwest.

https://www.worldfertilizer.com/environment/09062026/switch-bioworks-launches-microbial-fertilizer-trial//

Want to stay ahead in biotech? Subscribe to our newsletter for more 🧬https://www.syntheticbiologysummit.com/2027/early-bird?utm_source=Newsletter&utm_medium=Newsletter&utm_campaign=Digest_649&utm_content=Button%203

Pioneer Labs has introduced Defined Mars Media (DMM), a chemically defined simulant designed to replicate the nutrient c...
06/18/2026

Pioneer Labs has introduced Defined Mars Media (DMM), a chemically defined simulant designed to replicate the nutrient composition of Martian regolith for biological research. This innovative medium allows scientists to explore microbial growth and nutrient sourcing on Mars, supporting future space missions aimed at sustainable human habitation. DMM will be available through collaboration with Space Resources Technologies, enhancing research capabilities in astrobiology and in situ resource utilization.

https://www.pioneer-labs.org/p/how-do-you-simulate-mars-on-earth

Want to stay ahead in biotech? Subscribe to our newsletter for more 🧬https://www.syntheticbiologysummit.com/2027/early-bird?utm_source=Newsletter&utm_medium=Newsletter&utm_campaign=Digest_649&utm_content=Button%203

The Bezos Centre for Sustainable Protein and the Microbial Food Hub, in collaboration with Undaunted at Imperial College...
06/18/2026

The Bezos Centre for Sustainable Protein and the Microbial Food Hub, in collaboration with Undaunted at Imperial College London, has launched the Sustainable Food Accelerator, a 12-month, equity-free program aimed at supporting early technology readiness level ventures in sustainable food. The initiative focuses on enhancing commercial viability by providing selected startups with funding, scale-up facilities, and access to corporate partners, with applications opening on July 13, 2026.

https://airtable.com/appbsB2aWP1HnFmeL/pagOtdMycDaOHcz57/form

Want to stay ahead in biotech? Subscribe to our newsletter for more 🧬https://www.syntheticbiologysummit.com/2027/early-bird?utm_source=Newsletter&utm_medium=Newsletter&utm_campaign=Digest_649&utm_content=Button%203

Professor Ronjon Nag, founder of R42 Group and a prominent figure at Stanford University, has been honored with an Offic...
06/18/2026

Professor Ronjon Nag, founder of R42 Group and a prominent figure at Stanford University, has been honored with an Officer of the Order of the British Empire (OBE) for his impactful work in artificial intelligence and entrepreneurship. With a career spanning from early AI applications in mobile technology to current initiatives tackling aging-related diseases, Nag leads multiple ventures including Superbio.ai and Agemica, and invests in innovative longevity companies.

https://www.gov.uk/government/publications/birthday-honours-2026-overseas-and-international-list/the-kings-birthday-honours-2026-overseas-and-international-list-order-of-the-british-empire

Want to stay ahead in biotech? Subscribe to our newsletter for more 🧬https://www.syntheticbiologysummit.com/2027/early-bird?utm_source=Newsletter&utm_medium=Newsletter&utm_campaign=Digest_649&utm_content=Button%203

BioAge Labs has initiated the QUELL-CV Phase 2 trial for BGE-102, an oral NLRP3 inhibitor targeting cardiovascular risk ...
06/18/2026

BioAge Labs has initiated the QUELL-CV Phase 2 trial for BGE-102, an oral NLRP3 inhibitor targeting cardiovascular risk in patients with elevated systemic inflammation. The trial aims to evaluate the drug's efficacy in reducing high-sensitivity C-reactive protein (hsCRP) levels, with topline data expected in late 2026, following promising Phase 1 results.

https://www.globenewswire.com/news-release/2026/06/16/3312476/0/en/bioage-labs-announces-first-participant-dosed-in-quell-cv-a-phase-2-proof-of-concept-trial-of-bge-102-a-novel-oral-nlrp3-inhibitor-in-patients-at-elevated-cardiovascular-risk.html

Want to stay ahead in biotech? Subscribe to our newsletter for more 🧬
https://www.syntheticbiologysummit.com/2027/early-bird?utm_source=Newsletter&utm_medium=Newsletter&utm_campaign=Digest_649&utm_content=Button%203

Address

Pleasant Hill, CA

Website

,

Alerts

Be the first to know and let us send you an email when Synbiobeta posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Business

Send a message to Synbiobeta:

Shortcuts

Share

Category